A high level of arginase 1 (ARG1) expression by MDSCs depletes L-arginine in the tumor microenvironment, leading to downregulation of the CD3 ζ-chain of the TCR complex and proliferative arrest of T cells (24). This evidence concerns the gene ARG1 and neoplasm.